EAST RUTHERFORD, N.J., April 25 /PRNewswire-FirstCall/ -- Cambrex
Corporation (NYSE: CBM) is pleased to announce that Dr. Daniel Marshak, Vice
President and Chief Technology Officer, Biotechnology will participate in the
Wall Street Reporter Magazine, Inc. Stem Cell Roundtable Conference Call on
Tuesday, April 26th, at 2:00 PM eastern time. Dr. Marshak will join other
distinguished experts in a lively discussion on stem cell technologies and
commercial opportunities.
(Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO )
Interested parties can listen to the roundtable conference call via
telephone by dialing +1 918-222-7424 and entering the access code 9043.
About Cambrex
Cambrex is a global, diversified life sciences company dedicated to
providing products and services to accelerate and improve the discovery and
commercialization of human therapeutics. The Company employs approximately
1900 worldwide. For more information, please visit http://www.cambrex.com.
SOURCE Cambrex Corporation
 back to top
Related links:
http://www.cambrex.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO
Company News On-Call:
http://www.prnewswire.com/comp/134219.html
CONTACT:
Anne-Marie Hess, Director Investor Relations
& Corporate Communications, +1-201-804-3062, or
annemarie.hess@cambrex.com
|
